OPHI CollPlant Biotechnologies Ltd
Fundamentals / CIK 0001631487 / USDCollPlant Biotechnologies Ltd reported $2.37M in revenue and a net loss of $11.49M for the fiscal year ended December 31, 2025 (up 360.4% year over year), with a 64.8% gross margin and a -484.3% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OPHI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$2.37M +360.4% YoY
-
Operating Income FY 2025-$11.48M -484.3% margin
-
Net Income FY 2025-$11.49M -484.6% net margin
-
Diluted EPS FY 2025-$0.94 Split-adjusted
-
Free Cash Flow FY 2025-$9.45M -398.4% FCF margin
-
Cash & ST Investments Dec 31, 2025$5.59M Total debt: $2.85M
Annual revenue and net income
9 fiscal years (2017 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.37M | $515K | $10.96M | $299K | $15.64M | $6.14M | $2.32M | $5.01M | $463K |
| Cost of Revenue | $835K | $1.62M | $1.99M | $400K | $2.00M | $3.00M | $1.88M | $1.66M | $48K |
| Gross Profit | $1.54M | -$1.11M | $8.97M | -$101K | $13.64M | $3.13M | $439K | $3.35M | $415K |
| Research & Development | $8.19M | $10.52M | $10.48M | $10.26M | $7.63M | $4.07M | $4.41M | $3.88M | $584K |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | $3.66M | $3.72M | $2.47M |
| Total Operating Expenses | -- | -- | -- | -- | -- | $34K | $3.30M | $2.18M | -- |
| Operating Income | -$11.48M | -$17.25M | -$7.51M | -$17.10M | $65K | -$5.60M | -$7.63M | -$4.25M | -$5.96M |
| EBITDA | -$10.57M | -$16.21M | -$6.41M | -$16.02M | $838K | -$4.94M | -$7.09M | -$3.90M | -$5.73M |
| Interest Income | $380K | $738K | $788K | $321K | $219K | -- | -- | $440K | $74K |
| Interest Expense | -- | -- | -- | -- | -- | -- | $3.30M | $2.18M | $47K |
| Income Tax Expense | -- | $45.99M | $59.99M | -- | -- | -- | -- | -- | -- |
| Net Income | -$11.49M | -$16.61M | -$7.02M | -$16.93M | $237K | -$5.77M | -$11.16M | -$6.25M | -$6.05M |
| Basic EPS | -$0.94 | -$1.45 | -$0.62 | -$1.53 | $0.02 | -$0.84 | -$2.23 | $1.43 | -- |
| Diluted EPS | -$0.94 | -$1.45 | -$0.62 | -$1.53 | $0.02 | -$0.84 | -$2.23 | $1.43 | -- |
| Basic Shares Outstanding | 12.2M | 11.5M | 11.4M | 11.0M | 10.0M | 6.9M | 5.0M | 4.4M | 2.7M |
| Diluted Shares Outstanding | 12.2M | 11.5M | 11.4M | 11.0M | 12.0M | 6.9M | 5.0M | 4.4M | 2.7M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $5.59M | $11.91M | $26.67M | $29.65M | $13.15M | $3.33M | $3.79M | $5.35M | $4.75M |
| Cash & Short-Term Investments | $5.59M | $11.91M | $26.67M | $29.65M | $13.15M | $3.33M | $3.79M | $5.35M | $4.75M |
| Accounts Receivable, Net | $1.0K | $150K | -- | $9.0K | $270K | $830K | $79K | -- | -- |
| Inventory | $573K | $440K | $714K | $1.43M | $1.08M | $1.26M | $888K | $814K | $202K |
| Total Current Assets | $6.75M | $13.18M | $28.02M | $31.66M | $45.09M | $5.68M | $5.04M | $7.17M | $6.46M |
| Property, Plant & Equipment, Net | $1.46M | $2.29M | $2.79M | $2.97M | $2.73M | $2.11M | $2.33M | $1.41M | $1.03M |
| Intangible Assets | $73K | $131K | $188K | $245K | $243K | $82K | -- | -- | -- |
| Total Non-Current Assets | $4.04M | $5.53M | $6.10M | $6.11M | $6.14M | $5.17M | $5.71M | $1.58M | $1.62M |
| Total Assets | $10.79M | $18.71M | $34.13M | $37.77M | $51.22M | $10.84M | $10.75M | $8.75M | $8.09M |
| Accounts Payable | $610K | $870K | $980K | $1.13M | $1.03M | $798K | $833K | $622K | $843K |
| Short-Term Debt | -- | -- | -- | $321K | $219K | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | $32K | $207K | $942K | $970K | -- |
| Total Current Liabilities | $2.67M | $2.97M | $3.25M | $3.10M | $3.01M | $3.39M | $3.46M | $2.23M | $1.42M |
| Long-Term Debt | -- | -- | -- | -- | -- | $11K | $68K | $97K | $41K |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $980K | -- |
| Total Non-Current Liabilities | $2.03M | $2.27M | $2.54M | $2.38M | $3.09M | $2.98M | $3.21M | $1.10M | $4.05M |
| Total Liabilities | $4.70M | $5.25M | $5.79M | $5.49M | $6.10M | $6.36M | $6.66M | $3.33M | $5.47M |
| Total Debt (incl. Leases) | $2.85M | $3.08M | $3.16M | $3.23M | $3.83M | $3.40M | $3.66M | $97K | $41K |
| Common Stock | $5.49M | $4.98M | $4.98M | $4.87M | $4.66M | $2.93M | $2.37M | -- | -- |
| Retained Earnings | -$124.8M | -$113.3M | -$96.74M | -$89.72M | -$72.80M | -$73.03M | -$67.26M | -$56.10M | -$50.30M |
| Accumulated Other Comp. Income | -$969K | -$969K | -$969K | -$969K | -- | -- | -- | -- | -- |
| Total Stockholders' Equity | $6.08M | $13.46M | $28.34M | $32.28M | $45.12M | $4.48M | $4.09M | $5.42M | $5.17M |
| Total Equity | $6.08M | $13.46M | $28.34M | $32.28M | $45.12M | $4.48M | $4.09M | $5.42M | $5.17M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $5.59M | $11.91M | $26.67M | $29.65M | $13.15M | $3.33M | $3.79M | $5.35M |
| Cash & Short-Term Investments | $5.59M | $11.91M | $26.67M | $29.65M | $13.15M | $3.33M | $3.79M | $5.35M |
| Accounts Receivable, Net | $1.0K | $150K | -- | $9.0K | $270K | $830K | $79K | -- |
| Inventory | $573K | $440K | $714K | $1.43M | $1.08M | $1.26M | $888K | $814K |
| Total Current Assets | $6.75M | $13.18M | $28.02M | $31.66M | $45.09M | $5.68M | $5.04M | $7.17M |
| Property, Plant & Equipment, Net | $1.46M | $2.29M | $2.79M | $2.97M | $2.73M | $2.11M | $2.33M | $1.41M |
| Intangible Assets | $73K | $131K | $188K | $245K | $243K | $82K | -- | -- |
| Total Non-Current Assets | $4.04M | $5.53M | $6.10M | $6.11M | $6.14M | $5.17M | $5.71M | $1.58M |
| Total Assets | $10.79M | $18.71M | $34.13M | $37.77M | $51.22M | $10.84M | $10.75M | $8.75M |
| Accounts Payable | $610K | $870K | $980K | $1.13M | $1.03M | $798K | $833K | $622K |
| Short-Term Debt | -- | -- | -- | $321K | $219K | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | $32K | $207K | $942K | $970K |
| Total Current Liabilities | $2.67M | $2.97M | $3.25M | $3.10M | $3.01M | $3.39M | $3.46M | $2.23M |
| Long-Term Debt | -- | -- | -- | -- | -- | $11K | $68K | $97K |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | $980K |
| Total Non-Current Liabilities | $2.03M | $2.27M | $2.54M | $2.38M | $3.09M | $2.98M | $3.21M | $1.10M |
| Total Liabilities | $4.70M | $5.25M | $5.79M | $5.49M | $6.10M | $6.36M | $6.66M | $3.33M |
| Total Debt (incl. Leases) | $2.85M | $3.08M | $3.16M | $3.23M | $3.83M | $3.40M | $3.66M | $97K |
| Common Stock | $5.49M | $4.98M | $4.98M | $4.87M | $4.66M | $2.93M | $2.37M | -- |
| Retained Earnings | -$124.8M | -$113.3M | -$96.74M | -$89.72M | -$72.80M | -$73.03M | -$67.26M | -$56.10M |
| Accumulated Other Comp. Income | -$969K | -$969K | -$969K | -$969K | -- | -- | -- | -- |
| Total Stockholders' Equity | $6.08M | $13.46M | $28.34M | $32.28M | $45.12M | $4.48M | $4.09M | $5.42M |
| Total Equity | $6.08M | $13.46M | $28.34M | $32.28M | $45.12M | $4.48M | $4.09M | $5.42M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$11.49M | -$16.61M | -$7.02M | -$16.93M | $237K | -$5.77M | $11.16M | -$6.25M | -$6.05M |
| Depreciation & Amortization | $912K | $1.04M | $1.10M | $1.08M | $773K | $660K | $539K | $342K | $230K |
| Stock-Based Compensation | $999K | $1.72M | $1.94M | $2.17M | $1.60M | $1.67M | $1.12M | $1.43M | $956K |
| Change in Working Capital | -- | -- | -- | -- | -- | -$1.12M | $247K | -$1.15M | -- |
| Change in Receivables | $149K | -$150K | $9.0K | $261K | $560K | -$751K | $437K | -$439K | -$38K |
| Change in Inventory | -$129K | $280K | $749K | -$312K | $181K | -$374K | -$74K | -$653K | -$59K |
| Change in Payables | -$260K | -$110K | -$153K | $99K | $236K | -$35K | $228K | -$112K | -- |
| Operating Cash Flow | -$9.42M | -$14.09M | -$2.76M | -$13.70M | $2.50M | -$4.45M | -$5.70M | -$1.22M | -$4.97M |
| Capital Expenditure | -$28K | -$483K | -$954K | -$1.27M | -$1.43M | -$437K | -$1.49M | -$832K | -$127K |
| Free Cash Flow | -$9.45M | -$14.58M | -$3.72M | -$14.97M | $1.07M | -$4.89M | -$7.19M | -$2.05M | -$5.09M |
| Purchases of Investments | -- | -- | -- | -$20.00M | -$30.00M | -- | -- | -- | -- |
| Investing Cash Flow | -$27K | -$539K | -$1.16M | $28.92M | -$31.56M | -$519K | -$1.46M | -$832K | -$127K |
| Common Stock Issued | -- | -- | -- | -- | $50K | -- | $5.44M | $2.78M | $8.15M |
| Financing Cash Flow | $3.10M | $9.0K | $1.11M | $1.87M | $38.76M | $4.46M | $5.41M | $2.75M | $9.11M |
| Net Change in Cash | -$6.32M | -$14.77M | -$3.19M | $16.49M | $9.85M | -$445K | -$1.75M | $704K | $4.01M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.8% | -215.5% | 81.8% | -33.8% | 87.2% | 51.1% | 18.9% | 66.9% | 89.6% |
| Operating Margin | -484.3% | -3349.7% | -68.5% | -5718.1% | 0.4% | -91.2% | -329.2% | -84.7% | -1286.6% |
| Net Profit Margin | -484.6% | -3225.0% | -64.0% | -5660.5% | 1.5% | -94.1% | -481.6% | -124.6% | -1306.9% |
| Return on Equity (ROE) | -188.9% | -123.3% | -24.8% | -52.4% | 0.5% | -129.0% | -273.1% | -115.3% | -117.0% |
| Return on Assets (ROA) | -106.5% | -88.8% | -20.6% | -44.8% | 0.5% | -53.3% | -103.8% | -71.4% | -74.8% |
| Current Ratio | 2.53x | 4.44x | 8.62x | 10.20x | 14.96x | 1.68x | 1.46x | 3.21x | 4.56x |
| Quick Ratio | 2.31x | 4.29x | 8.40x | 9.74x | 14.60x | 1.30x | 1.20x | 2.85x | 4.41x |
| Debt to Equity | 0.47x | 0.23x | 0.11x | 0.10x | 0.08x | 0.76x | 0.90x | 0.02x | 0.01x |
| Revenue Growth (YoY) | +360.4% | -95.3% | +3565.2% | -98.1% | +154.9% | +164.8% | -53.8% | +982.9% | -- |
| Gross Profit Growth (YoY) | -- | -112.4% | -- | -100.7% | +335.0% | +614.1% | -86.9% | +708.4% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -26403.1% | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -- | -- | -- | -7241.4% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -7750.0% | -- | -- | -255.9% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -647.7% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -1495.3% | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -78.2% | -90.3% | -15.9% | -84.4% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.